Literature DB >> 8154523

Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics.

S S Hayreh1, M B Zimmerman, P Podhajsky.   

Abstract

We analyzed data on 1,108 patients (1,229 eyes) with various types of retinal vein occlusion. Retinal vein occlusion was classified into six distinct clinical types: (I) nonischemic and (II) ischemic central retinal vein occlusion, (III) nonischemic and (IV) ischemic hemicentral retinal vein occlusion, and (V) major and (VI) macular branch retinal vein occlusion. Retinal vein occlusion occurred more often in men than women. The age range of patients was between 14 and 92 years, with 570 of 1,108 patients (51%) 65 years or older; however, 99 of 620 (16%), 15 of 154 (10%), and 17 of 375 (5%) of the patients with central, hemicentral, and branch retinal vein occlusion, respectively, were younger than 45 years. The cumulative probability of developing a second episode of the same or a different type of retinal vein occlusion in the same eye was 0.9% within two years and 2.5% within four years, and in the fellow eye was 7.7% and 11.9%, respectively. The cumulative probability of conversion of nonischemic to ischemic central retinal vein occlusion at six months and 18 months was 13.2% and 18.6%, respectively, in persons 65 years of age or older and 6.7% and 8.1%, respectively, in persons 45 to 64 years of age.

Entities:  

Mesh:

Year:  1994        PMID: 8154523     DOI: 10.1016/s0002-9394(14)70001-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  94 in total

Review 1.  Thrombophilia: genetic polymorphisms and their association with retinal vascular occlusive disease.

Authors:  M Chak; G R Wallace; E M Graham; M R Stanford
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

2.  Central retinal venous occlusion with co-existent thrombotic thrombocytopenic purpura and antiphospholipid syndrome.

Authors:  P T Murphy; P Rao
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

Review 3.  Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion.

Authors:  Tasanee Braithwaite; Afshan A Nanji; Paul B Greenberg
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

Review 4.  The management of retinal vein occlusion: is interventional ophthalmology the way forward?

Authors:  H Shahid; P Hossain; W M Amoaku
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

5.  Prospective multicenter study of visual outcomes following three different treatments for macular edema associated with branch retinal vein occlusion: a study by the Japanese BRVO study group.

Authors:  Seiyo Harino; Kenichiro Bessho; Teruyo Kida
Journal:  Jpn J Ophthalmol       Date:  2012-02-23       Impact factor: 2.447

6.  Pulse-wave analysis of optic nerve head circulation is significantly correlated with brachial-ankle pulse-wave velocity, carotid intima-media thickness, and age.

Authors:  Tomoaki Shiba; Mao Takahashi; Yuichi Hori; Takatoshi Maeno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-21       Impact factor: 3.117

7.  Natural history of visual outcome in central retinal vein occlusion.

Authors:  Sohan Singh Hayreh; Patricia A Podhajsky; M Bridget Zimmerman
Journal:  Ophthalmology       Date:  2010-08-17       Impact factor: 12.079

Review 8.  Central retinal vein occlusion: modifying current treatment protocols.

Authors:  M Ashraf; A A R Souka; R P Singh
Journal:  Eye (Lond)       Date:  2016-02-12       Impact factor: 3.775

9.  [Gingival hyperplasia and visual reduction].

Authors:  M Haustein; J Babatz; F Sommer; J Radke; C Hoffmann; L E Pillunat; D Sandner
Journal:  Ophthalmologe       Date:  2011-11       Impact factor: 1.059

10.  Citalopram-associated central retinal vein occlusion.

Authors:  Alastair D Hardisty; Christopher M Hemmerdinger; Say Aun Quah
Journal:  Int Ophthalmol       Date:  2008-06-11       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.